TITLE

Pathological Gambling and Alcohol Use Disorder

AUTHOR(S)
Grant, Jon E.; Kushner, Matt G.; Suck Won Kim
PUB. DATE
June 2002
SOURCE
Alcohol Research & Health;2002, Vol. 26 Issue 2, p143
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Problematic gambling is more common among people with alcohol use disorders (AUDs) (i.e., either alcohol abuse or dependence) compared with those without AUDs. This association holds true for people in the general population and is even more pronounced among people receiving treatment. Mo broadly accepted explanation for the link between problematic gambling and AUD currently exists. The available literature suggests that common factors may increase the risk for both conditions. For example, a defect of functioning in a particular brain system may underlie both conditions. This hypothesis should be further developed using brain imaging and psychopharmacological studies. Effective treatment and prevention will require additional research into relevant associations on both the event level (e.g., the effects of drinking on gambling behavior and vice versa) and the syndrome level (e.g., the relative onset and course of each condition among those who have either one or both disorders). A prudent interpretation of the available data suggests careful screening and treatment when necessary for problematic gambling among people with alcohol abuse and for alcohol abuse among people with gambling problems.
ACCESSION #
12556142

 

Related Articles

  • The Clinically Meaningful Link Between Alcohol Use and Attention Deficit Hyperactivity Disorder. Smith, Bradley H.; Molina, Brooke S.g.; Pelham, William E. // Alcohol Research & Health;2002, Vol. 26 Issue 2, p122 

    Attention deficit hyperactivity disorder (ADHD) is a childhood mental health disorder that can lead to alcohol and other drug (AOD)-related problems if it persists into adolescence and adulthood. Several findings suggest that ADHD contributes to the development of AOD use disorders. ADHD...

  • Drug cuts alcoholics' relapse rates in half, but it's no magic bullet.  // Modern Medicine;Mar95, Vol. 63 Issue 3, p6 

    Features the Naltrexone HCl (Revia) opioid-receptor antagonist for the treatment of alcohol dependence. Approval by the US Food and Drug Administration; Safety; Reduction of relapse states; Side effects.

  • Drug therapy can improve the outcome of treatment in patients with alcoholism.  // Outcomes & Accountability Alert;Oct99, Vol. 4 Issue 10, p3 

    Presents information on drug treatments for alcoholism. Calcium carbamide; Naltrexone; Nalmefene; Effectiveness of the treatments.

  • Neuroscience: Implications for treatment. Petrakis, Ismene; Krystal, John // Alcohol Health & Research World;1997, Vol. 21 Issue 2, p157 

    Discusses the implications of alcoholism treatment. Action of naltrexone and acamprosate on treating alcoholism; Medications which may alleviate symptoms of anxiety and depression in alcoholics.

  • Newly approved Naltrexone can help reduce craving and prevent relapse. Schmidt, Laura M. // Addiction Letter;Feb95, Vol. 11 Issue 2, p1 

    Reports on the US Food and Drug Administration's approval of the use of naltrexone as a safe and effective adjunct to psychosocial treatments for alcoholism. DuPont Merck Pharmaceutical Corp. as drug's manufacturer; Efficacy of the naltrexone in blocking the brain's mechanisms for alcohol...

  • A sobering pill for problem drinkers.  // Health (Time Inc. Health);May/Jun95, Vol. 9 Issue 3, p22 

    Reports on the use of naltrexone as a treatment for problem drinkers. Interruption for the brain's cravings for alcohol; Action of the drug; Study of alcoholics taking the drug.

  • A pill to combat alcoholism.  // U.S. News & World Report;1/30/95, Vol. 118 Issue 4, p15 

    Discusses how the prescription drug naltrexone, which has been used for 11 years to help heroin addicts stay clean, is about to be marketed as a way to help alcoholics stay sober. Claims of the DuPont Merck Pharmaceutical Co. on how the pill dampens alcohol cravings; Cost of the drug, sold...

  • A new assault on addiction. Cowley, Geoffrey; Biddle, Nina Archer // Newsweek;1/30/1995, Vol. 125 Issue 5, p51 

    Comments on approval by the Food and Drug Administration of the drug naltrexone as a chemical treatment for alcoholism. Naltrexone's 20-year use to help former drug users stay clean; How DuPont Merck Pharmaceutical Co. marketed the drug as Trexan in 1984 and is rechristening it ReVia and...

  • Treatment drug for heroin addiction now approved by FDA to treat alcoholism.  // Jet;2/20/95, Vol. 87 Issue 15, p22 

    Reports on the US Food and Drug Administration's (FDA) approval of the drug naltrexone for use in treating alcoholism. Use of drug to treat heroin addiction; DuPont Merck Pharmaceutical Corp.'s marketing of naltrexone.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics